| Financial Year |
March 31 2022 |
| Monetary Funds |
101,720,435.43 |
| Held-for-trading Financial Assets |
2,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
630,375,404.57 |
| Advances to Suppliers |
46,033,648.25 |
| Other Receivables |
341,966,364.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
366,721,227.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,868,709.98 |
| Other Current Assets |
222,039,130.69 |
| Total Current Assets |
1,753,119,714.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,962,315.11 |
| Long-term Equity Investment |
19,838,391.97 |
| Investment Properties |
151,258,263.57 |
| Fixed Assetes |
1,345,621,902.28 |
| Under-construction Projects |
793,162,553.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,030,943.76 |
| R&D expenses |
40,176,923.35 |
| Goodwill |
106,545,989.11 |
| Long-Term Deferred and Prepaid Expenses |
24,254,074.44 |
| Deferred Income Tax Assets |
10,102,296.14 |
| Other Non-Current Assets |
115,782,687.06 |
| Sub-Total of Non-Current Assets |
2,942,577,909.92 |
| Total Assets |
4,695,697,624.67 |
| Short-Term Loans |
1,240,558,492.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
727,636,891.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
92,006,900.93 |
| Taxes Payable |
88,760,144.68 |
| Interest Payable |
406,229,127.05 |
| Dividend Payable |
-- |
| Other payables |
1,051,835,196.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
981,879,983.47 |
| Other Current Liabilities |
47,319,110.72 |
| Sub-Total of Current Liabilities |
4,413,498,917.50 |
| Long-term Loans |
62,595,361.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,452,616.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
187,147,993.20 |
| Deferred Income Tax Liabilities |
5,698,679.71 |
| Other Non-Current Liabilities |
7,470,157.29 |
| Sub-Total of Non-Current Liabilities |
310,019,241.77 |
| Total Liabilities |
4,723,518,159.27 |
| Paid-In Capital(Or Share Stock) |
567,374,389.00 |
| Capital Surplus |
3,374,110,779.25 |
| Surplus Reserve |
19,581,565.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,954,585,178.08 |
| Minority Stockholder's Interest |
-14,754,014.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-13,066,519.72 |
| Owner's Equity（Stockholder's Equity） |
-27,820,534.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,695,697,624.67 |
